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M E T H O D S 
DETERMINATION OF ISLET C E L L ANTIBODIES USING AN 
ELISA SYSTEM WITH A PREPARATION OF RAT 
INSULINOMA (RIN A2) CELLS 
W . A . S C H E R B A U M , J . S E I B L E R , U . H E D D E R I C H , B . O . B O E H M , 1 M . S P E C K E R and E . F . P F E I F F E R 
Department of Internal Medicine I, Medizinische Klinik und Poliklinik University of U l m and 'Department of Endocrinology, 
University Hospital Frankfurt 
(Received 25 July 1988) 
SUMMARY An enzyme-linked immunosorbent assay 
(ELISA) was established for the detection of islet cell antibodies 
in human sera. The antigen was prepared from rat insulinoma 
(RIN A2) cells. Cells were dissociated in lysis buflfer and the 
lysate was centrifuged at 100,000 x g. The supernatant was used 
to coat microtiter ELISA plates (lOjig protein/ml in PBS 
pH 7-2). Non-specific binding sites on the plates were blocked 
with 2% PBS-BSA. Human test sera were preabsorbed on 
separate plates using 2% PBS-BSA and incubated on precoated 
plates at an optimal dilution of 1/10 in 60 mM PBS for 60 min at 
37°C. Phosphatase-labeled anti-human IgG serum and Phos-
phatase Substrate were applied and the reaction was stopped by 
adding 3 M NaOH. Out of 90 sera from type I diabetic patients, 
47 (52-2%) reacted in the new ELISA whereas none of 15 type II 
diabetics, 50 sera containing non-islet specific antibodies or 100 
normal controls were positive. In the same group of patients, 
ICA were positive in 63-3%. When both, the ELISA and con-
ventional ICA testing were applied, the number of positives was 
increased to 83%. The ICA-ELISA with the above described 
antigen preparation provides a well standardized and re-
producible test method which is highly specific for type I 
diabetes. It may therefore be useful for large Screening 
procedures. 
Key words: Islet cell antibodies, ELISA, RIN cell preparation 
I N T R O D U C T I O N 
T H E detection of islet cell antibodies ( I C A ) in the serum is 
a hal lmark of insulitis and type I (insulin-dependent) 
diabetes mellitus (1,2). U s i n g the indirect immunofluor-
escence ( I F L ) test on unfixed cryostat sections of human 
pancreas, 60-90% of patients are positive at the onset of 
disease, whereas i n normal individuals the antibodies 
occur in less than 1% of the cases (3-5). The presence in 
the serum of I C A points to an autoimmune form of 
diabetes even when the disease Starts atypically at an 
older age or when the diabetes can be init ially control led 
by ora l antidiabetic drugs (6-10). The detection of I C A 
C o r r e s p o n d e n c e : Dr. W. Scherbaum, Abteilung Innere Medizin I, 
Medizinische Klinik und Poliklinik der Universität, Robert-Koch-
Strasse 1, D 7900 Ulm, West Germany. 
may therefore be relevant to the initial aetiological 
Classification of diabetes (11). 
Prospective family studies as well as the systematic 
investigation of non-diabetic, H L A identical twins and 
triplets of type I diabetics have shown that I C A may be 
present in the serum years before the cl inical manifes-
tation of diabetes and well before a deficiency of insul in 
secretion can be established by the sensitive i.v. glucose 
tolerance test (12,13). Therefore, the determination of 
I C A has become increasingly important to identify i n -
dividuals at risk to develop type I diabetes among pre-
disposed individuals (14-19) or i n popula t ion S c r e e n i n g 
programs (20-22). Unfortunately, the standardization of 
the convent ional immunofluorescence test for the 
detection of I C A has caused mul t ip le problems and the 
results vary considerably when different donor organs are 
used as a Substrate. W e now describe a reproducible 
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detection System for I C A using an enzyme-l inked 
immunosorbent assay ( E L I S A ) with a preparation of the 
R I N A 2 cell line. 
M A T E R I A L S A N D M E T H O D S 
Sera 
The sera from 90 type I diabetics (32 males/58 females, mean age 
19 yrs, ränge 17-45 yrs) were investigated. The duration of diabetes 
varied between onset of disease and a 17 yr course. Thirty sera could be 
gained within three months of diagnosis. 
Fifteen sera from type II diabetics were tested (10 males/5 females, 
mean age 56 yrs, ränge 39-74 yrs). Only patients with more than 2 yrs of 
diabetes were studied. A l l patients were under treatment with diet and 
antidiabetic drugs. Cases of secondary diabetes were excluded. 
To test the specificity of results, 50 sera from non-diabetic individuals 
were also investigated. Twelve of them had autoantibodies (Ab) to 
exocrine pancreatic tissue, five thyroid microsomal Ab, two adreno-
cortical Ab, six gastric parietal cell Ab, five d s D N A Ab, 10 other 
antinuclear Ab, five smooth muscle Ab, five anti-mitochondrial Ab. 
One hundred sera from apparently healthy blood donors were also 
investigated. None of these normals had a family history of type I 
diabetes. The mean age of the control group was 24-5 yrs, ränge: 
10-30 yrs. 
A l l sera were stored at - 2 0 ° C . Before testing in the cell assay, the sera 
were decomplemented by a 30 min incubation in a water bath at 56°C. 
R I N A I C e l l s 
This insulin-producing rat insulinoma cell line R I N A2 derived 
from the subclone R I N m5F was kindly gained from Prof. Ammon, 
Tübingen. The cells were cultured in R P M I 1640 medium supplemented 
with 10% v/v heat-inactivated fetal calf serum, 5% glutamin, penicillin 
lOOU/ml and streptomycin lOOjig/ml at 37°C in an atmosphere 
containing 95% air and 5% C 0 2 . 
The cells were fed every second day and passaged every four days. 
The cells were dissociated from the culture surface by incubation with 
t rypsin-EDTA Solution (0-5 mg/ml and 0-2 mg/ml respectively in 
calcium/magnesium-free Hank's balanced salt Solution) for 4-8 min at 
37°C. Cells were then washed twice in their original medium and 
resuspended. At the final harvesting, the cells were washed three times in 
R P M I 1640 without fetal calf serum. 
P r e p a r a t i o n of P a n c r e a t i c I s l e t C e l l s f r o m Rat P a n c r e a s 
Wistar rats with a body weight of about 150g were used throughout. 
Islets were prepared after the method of Lasy and Kostaniovsky (22). 
After nembutal anesthesia, the pancreas was ballooned by an intra-
aortic injection of a Solution of neutral red. The pancreas was removed, 
mechanically minced with scissors and digested with collagenase 
(Sigma, type V, 7*5 mg/ml tissue) at 37°C. After microscopic control the 
digestion was stopped with ice cold Hank's Solution. Exocrine and 
endocrine pancreas were separated using the discontinuous Ficoll 
density gradient centrifugation. The islets were selectively picked with a 
pipett under a stereo microscope. Picked islets were incubated in E G T A 
Solution for 30 min at room temperature. The yield of islets was about 
300/rat, and from these, about 200,000-300,000 islet cells were gained. 
A n t i g e n P r e p a r a t i o n 
R I N A2 cells were washed three times in phosphate buffered saline for 
10 min each, and centrifuged at 200 x g in between. Lysis of cells was 
obtained by incubation with lysis buffer (Triton X-100 lO ml /L , Trasylol 
50ml/L, P M S F 0-17g/L, N a C l 8-8 g/L, Hepes l l - 9 g / L , p H 7-6) for 
90 min at 4°C under constant stirring. The lysate was subsequently 
centrifuged at 100,000 x g for 90 min at 4°C. 
The supernatant was designated as fraction A. For the isolation 
of the soluted membrane glycoproteins (23), the supernatant was 
further processed by affinity chromatography using Lentil-Lectin 
Sepharose 4B (Pharmacia): the supernatant was mixed with the gel and 
incubated overnight in the roller at 4 ° C It was then transmitted to the 
ice cooled chromatography column. The unbound fractions were 
washed with P B S + 1 M N a C l and eluted with PBS + 0-5 M methyl-
alpha-D-mannopyranosid. This preparation was designated as fraction 
B. The protein concentration was determined according to the method 
ofBradford (24). 
C o a t i n g of E L I S A P l a t e s 
To determine the antibody binding of patients' sera to surface 
membranes of intact islet cells, 100 ul of Suspension from freshly 
prepared viable rat islet cells and R I N A2 cells were submitted to 
microtiter plates ((a) Immulon M 129B, (b) Nunc-Immuno plate) at a 
density of 1 x 10 5cells/ml in R P M I 1640 medium. In different 
experiments, cells were seeded with or without preincubation of plates 
with poly-L-lysin (Sigma), respectively. The cell suspensions were 
primarily attached to the microtiter plates by centrifugation at 
100 x g for 5 min. Suspended cells were cultured for 24 h and they 
were finally washed twice by gentle incubation with PBS p H 7-4. 
For their use in E L I S A tests, the cells on coated plates either 
remained unfixed, or they were fixed with 4% paraformaldehyde or 
0-25% glutaraldehyde in different experiments. 
The coating of plates with islet cell preparations was performed with 
six different buffers. (a) 50 m M Carbonate buffer, p H 9-6. (b) 50 m M 
Carbonate buffer, p H 7-2. (c) 0-2 M Carbonate buffer, p H 8-3. (d) 0-2 M 
Carbonate buffer. p H 7-2. (e) 150mM PBS, p H 7-2. (0 150mM PBS, 
p H 5-5. 
E L I S A Test P r o c e d u r e 
Coated plates were washed three times with PBS p H 7-4. Non-specific 
binding sites were blocked by incubation with 2% bovine serum 
albumin and subsequent washing with PBS. Human sera were diluted 
in 60 m M PBS buffer and applied in doubles. After incubation with sera 
for 60 min the plates were washed three times with Tris-Tween 01%, 
and incubated for 30 min with phosphatase-conjugated anti-human 
IgG (Tago) diluted 1/2,000 in PBS. After washing four times, 100 1^ of 
Substrate Solution were added to each well. The reaction was stopped 
after visual control by adding 3 M N a O H . The coloured reaction 
product was measured at 410nm with a Dynatech microELISA 
autoreader M R 600. 
D e t e c t i o n ofBSA A n t i b o d i e s 
Because all E L I S A plates had been blocked with 2% BSA and the 
R I N cells had been originally cultured with B S A , the positive reaction 
of a serum could be due to the presence of albumin antibodies. There-
fore, all positive sera were preabsorbed on E L I S A plates coated with 2% 
BSA and they were then retested using the above E L I S A System. 
I n d i r e c t I m m u n o fluorescence Test 
For the detection of conventional I C A the indirect I F L test was 
applied using unfixed cryostat sections of human pancreas from a donor 
with blood group O (25). 
R E S U L T S 
Adhesion of Cells to the E L I S A M i c r o t i t e r Plates 
The adhesion of viable R I N A 2 cells and of freshly 
isolated rat islet cells to the microt i ter plates was in-
sufficient. It was only marginal ly improved by pre-
incubat ion of plates wi th P o l y - L - L y s i n . Even after 
extremely cautious washing and incubat ion procedures 
there were large gaps i n the or ig inal ly dense cell layer 
(Figure l a and lb ) . The attachment of cells was not 
improved after fixation wi th 4% paraformaldehyde, but 
fixation wi th 0-25% glutaraldehyde resulted in a good 
adhesion throughout the E L I S A procedure. 
98 S C H E R B A U M et a l 
Figure l(a). Phase contrast photography of an E L I S A microtitre 
plate coated with unfixed R I N A2 cells before further testing. 
Figure l(b). At the end of the E L I S A procedure many R I N A2 cells 
were washed off from the bottom both with native plates as well as after 
preincubation with Poly-L-Lysin . These holes caused an unacceptable 
non-specific binding of sera. 
E L I S A - I C A Test Results with V i a b l e Islet Cells 
The large gaps in the coat ing cell layer observed wi th 
unfixed or formalin-fixed islets resulted in a significant 
nonspecific b ind ing of serum components to the plates so 
that no reproducible results cou ld be obtained. W h e n 
glutaraldehyde-fixed R I N A 2 cells were used, the 
ind iv idua l E L I S A test results were not consistent and 
they d id not a l low to dist inguish type I diabetics from 
normal individuals . W h e n freshly isolated glutar-
aldehyde-fixed rat islet cells were used, the mean b inding 
of type I diabetic sera was higher i n each test than the one 
obtained wi th cont ro l sera (Figure 2). However , the i n -
div idual reproducibi l i ty of positive and negative test 
results was insufficient. The in t ra assay variance was 
94%, the inter assay variance was as high as 31%. This 
system was therefore abandoned. 
E L I S A with F r a c t i o n A f r o m R I N A 2 Cells 
E v a l u a t i o n of the optimal coating buffer F igure 3 shows 
the E L I S A test results in relat ion to the sort and p H of 
Figure 2. Results of an E L I S A using freshly isolated rat islet cells fixed 
with 0-25% glutaraldehyde. The sera from type I diabetics gave an 
increased overall binding as compared to controls. However, the 
individual test results were very variable and not clearly reproducible. 
(#), Type I diabetics; (X), normal controls. 
coat ing buffer used for the d i lu t ion of the antigen. The 
antigen (50 jil/well) was incubated overnight at 4°C. The 
further test condit ions were as described below (Figure 6). 
The highest b inding of diabetic sera and the best d iscr imi-
nat ion between diabetics and no rma l controls was 
achieved with a phosphate buffer p H 7-2. 
O p t i m a l antigen concentration for coating The R I N A 2 
cell fraction A was used at di lut ions 1/50-1/10,000. It is 
evident from Figure 4 that the best d iscr iminat ion 
between diabetic and normal human sera was obtained at 
a d i lu t ion of 1/200 which contained 10 jxg protein/ml . 
O p t i m a l serum d i l u t i o n The highest ant ibody b inding 
was obtained with a serum d i lu t ion of 1/5 (Figure 5). The 
absorpt ion values of both patients and controls 
ph9.6 ph7.2 
carbonate buffer 1 
ph8.3 ph7.2 





Figure 3. Influence of various coating buffers upon the I C A - E L I S A 
with the R I N A 2 cell preparation (fraction A). The mean values of 
results obtained with 10 ICA-positive type I diabetic patients and with 
10 controls are given in the figure. ( • ) , Type I diabetics; ( ü ) , normal 
controls. 
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Figure 4. Influence of the concentration of coating antigen upon I C A -
E L I S A test results. Fraction A from R I N A2 cells was diluted in PBS 
p H 7-2 as a coating buffer and 100 ul/well were used. The figure gives the 
mean values of results obtained with 10 sera from type I diabetics and 
from 10 normal controls. The best discrimination between the two 
groups was obtained at a serum dilution of 1/200 (= 10 ug protein/ml). 
(#), Type I diabetics; (X), normal controls. 
decreased wi th increasing serum di lu t ions used i n the 
assay. The best d i sc r imina t ion between patients and 
controls was obtained wi th sera appl ied 1/10. A t this 
d i lu t ion the mean value of patients versus mean value of 
controls was 2*72. 
E L I S A with F r a c t i o n B f r o m R I N A 2 Cells 
W h e n the membrane g lycopro te in fraction was used 
for coating, diabetic sera d i d not produce an increased 
1.0--
0 . 8 -
5 10 20 1*0 80 160 320 640 x W 
dilution of test serum 
Figure 5. Influence of the concentration of test serum upon the 
specific binding in the I C A - E L I S A . Fraction A from R I N A 2 cells was 
used at 1/200. PBS p H 7-2 as a coating buffer. The best discrimination 
between type I diabetic patients and controls was achieved at a serum 
concentration of 1/10. (#), Type I diabetics; (X), normal controls. 
Preabsorption of sera on BSA-coated plates 
lh at 37oc 
• 
coating of microtiter plates with RIN A2 c e l l f r a c t i o n A 
(100 u l / 10 ug/ml in PBS pH 7.2) 
18 h at 4<>C 
• 
wash 3x with PBS 
block non-specific binding s i t e s with 2% PBS-BSA 
60 min at 37 °C 
remove BSA by skipping of plates 
incubation of serum (100 u l , 1/10 i n PBS) 
60 min at 37 <>C 
wash 3x with TRIS buffer 
phosphatase-labeled anti-human IgG (100 u l , 1/5/000 i n PBS) 
30 min at 37 <>C 
wash 3x with TRIS buffer 
• 
Phosphatase Substrate (100 u l / 1 mg/ml Substrate) 
stop reaction with 100 ul 3M NaOH 
read absorption at 410 nm 
Figure 6. Schematic description of the optimal I C A - E L I S A using 
fraction A from the R I N A2 cell preparation. 
bind ing wi th any of the procedures appl ied for fraction A . 
Therefore, fraction B was not used for further testing. 
O n the basis of the results above described the E L I S A 
for I C A testing was applied as indicated in F igure 6. 
Specificity o f the islet cell a n t i b o d y — E L I S A and its cor-
r e l a t i o n with conventional I C A testing Forty-seven of 
the 90 sera (52-2%) from type I diabetic patients were 
positive in the new E L I S A . Fifty-seven (63-3%) were I C A -
positive as measured by the indirect immunofluorescence 
test. N o n e of the sera from type II diabetics or from 
patients with non-islet cell specific autoantibodies or 
controls was positive in the E L I S A . The results obtained 
with the E L I S A and with the I F L test on 30 sera from 
type I diabetics gained wi th in three months of diagnosis 
are given in Table 1. I C A were positive in 20 (67%), 
Table 1 Results of the I C A - E L I S A using fraction A from R I N A2 cells 
compared with the results obtained with conventional ICA deter-
mination using the indirect immunofluorescence test on unfixed 
cryostat sections of human pancreas. The 30 sera were obtained within 
the first three months of diagnosis of type I diabetes 
I C A ( I F L - T e s t ) 
p o s i t i v e n e g a t i v e 
E L I S A positive 14 5 
E L I S A negative 6 5 
100 S C H E R B A U M et a l 
E L I S A - I C A reacted i n 19 (63%) of the cases. W i t h a 
combina t ion of the two methods the number of positives 
was increased to 25 (83%). 
Antibodies to bovine serum a l b u m i n ( B S A ) Eleven out of 
80 sera (19%) from type I diabetics contained B S A anti-
bodies. After preabsorpt ion wi th B S A , eight of these sera 
remained posit ive i n the I C A - E L I S A indicat ing that they 
contained bo th B S A antibodies and islet cell antibodies. 
N o n e of the sera from type II diabetics, four of the sera 
from patients wi th associated autoantibodies and three 
out of 100 n o r m a l h u m a n sera were positive for B S A 
antibodies. 
D I S C U S S I O N 
The feasibility of I C A determinat ion i n large popula t ion 
Screening programs depends o n an easily reproducible 
and objective test System. F o l l o w i n g a Standard p ro tocol 
with the convent ional I F L test on unfixed cryostat 
sections of h u m a n pancreas even specialized laboratories 
recorded a wide var iabi l i ty of titres ranging from negative 
to 128. W i t h l ow titre sera the interlaboratory 
concordance for a posit ive result was only 52 -79% (20). 
This is main ly due to the subjective reading of the I F L 
test and the variance of human pancreases used as an 
antigen. 
The new E L I S A using a rat insu l inoma ( R I N A2) cell 
preparat ion for the detection of islet cell antibodies 
provides the advantage of easy s tandardizat ion and 
objective measurement of I C A . N o t only antibodies to 
membrane proteins but also reactivities directed to 
soluble islet cell proteins can be measured in the assay. 
This may expla in part of the positive E L I S A test results 
in ICA-negat ive sera from type I diabetics. In contrast to 
the immunofluorescence test, the E L I S A may also detect 
low affinity antibodies. The negative E L I S A - I C A results 
wi th sera conta in ing I C A as determined by indirect im-
munofluorescence may be explained by the l imi ted cross-
reactivity of h u m a n sera wi th the R I N cell antigens. 
The disease specificity of E L I S A - I C A is shown by the 
fact that patients and n o r m a l individuals as well as 
patients wi th non-diabetes-specific antibodies were 
constantly negative in the new assay. L i k e convent ional 
I C A the E L I S A - I C A can therefore be considered as a 
marker of au to immune insulit is . W i t h the E L I S A System 
here described the lower l imi t of detection of islet cell 
specific autoantibodies i n the serum of type I diabetics 
was clearly elevated. The two tests may be used comple-
mentary since b io logica l ly false positive results are very 
rare in the I F L (3-5) and they were not detected in our 
E L I S A . 
Some authors have tried to perform an E L I S A for the 
detection of islet cell surface antibodies ( I C S A ) by coating 
microtitre plates wi th fixed pr imary rat islet cells (26) or 
with R I N m 5 F cells (27). The promis ing first reports, 
however, were not reproduced by other authors. In our 
o w n experiments, the at tachment of native cells to the 
precoated plates was insufficient to resist the E L I S A 
procedure. E v e n wi th gentle washing cell-free holes 
appeared which p roduced an unacceptable increase of 
non-specific b ind ing to the plates. Sufficient attachment 
of cells was achieved by fixation wi th 0-25% glutar-
aldehyde, but this resulted in an increase of false negative 
and false posit ive results. T h e change of islet cell antigens 
by fixatives has also been documented in previous reports 
(28,29). 
T h e presence of B S A ant ibodies in human sera is well 
explained by the ingest ion of c o w mi lk or beef (30), but it 
may disturb the Interpretation of a positive I C A - E L I S A 
result so that a preabsorp t ion of sera wi th B S A is recom-
mended. B S A antibodies have also been detected by 
other authors (31,32). U s i n g an immunoprecip i ta t ion 
method, C o l m a n et al. (32) were able to discriminate the 
B S A reactivity f rom I C A . In contrast to the above 
ment ioned report, we found an increased prevalence of 
B S A antibodies i n the sera from type I diabetic. A l t h o u g h 
this finding may be due to a selection of our patients it is 
wor th while to study B S A antibodies i n a larger group of 
type I diabetic patients. 
T h e I C A - E L I S A here described is well standardized 
and highly specific for type I diabetes. It may therefore be 
considered as a valuable t o o l for islet cell ant ibody testing 
i n large Screening investigations. Fur ther research should 
be a imed at the i so la t ion of the islet cell antigen which 
w i l l a l low to establish the op t ima l test for I C A deter-
mina t ion . 
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